Correlation Between Talaris Therapeutics and Anebulo Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Talaris Therapeutics and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talaris Therapeutics and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Talaris Therapeutics and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Talaris Therapeutics and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talaris Therapeutics with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talaris Therapeutics and Anebulo Pharmaceuticals.

Diversification Opportunities for Talaris Therapeutics and Anebulo Pharmaceuticals

0.0

Correlation Coefficient

Talaris Therapeutics  Anebulo Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Talaris and Anebulo is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Talaris Therapeutics and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Talaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talaris Therapeutics are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Talaris Therapeutics i.e., Talaris Therapeutics and Anebulo Pharmaceuticals go up and down completely randomly.

Pair Corralation between Talaris Therapeutics and Anebulo Pharmaceuticals

If you would invest  125.00  in Anebulo Pharmaceuticals on December 21, 2024 and sell it today you would earn a total of  73.00  from holding Anebulo Pharmaceuticals or generate 58.4% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Talaris Therapeutics  vs.  Anebulo Pharmaceuticals

Talaris Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Talaris Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Talaris Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Anebulo Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Anebulo Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile technical and fundamental indicators, Anebulo Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Talaris Therapeutics and Anebulo Pharmaceuticals

The main advantage of trading using opposite Talaris Therapeutics and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talaris Therapeutics position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.

The idea behind Talaris Therapeutics and Anebulo Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.